Perkins Capital Management’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-70,000
| Closed | -$281K | – | 92 |
|
|
2023
Q4 | $281K | Sell |
70,000
-197,164
| -74% | -$791K | 0.24% | 74 |
|
|
2023
Q3 | $731K | Sell |
267,164
-300
| -0.1% | -$821 | 0.72% | 44 |
|
|
2023
Q2 | $1.79M | Sell |
267,464
-7,500
| -3% | -$50.1K | 1.56% | 22 |
|
|
2023
Q1 | $1.75M | Sell |
274,964
-2,300
| -0.8% | -$14.7K | 1.65% | 20 |
|
|
2022
Q4 | $685K | Sell |
277,264
-7,800
| -3% | -$19.3K | 0.72% | 42 |
|
|
2022
Q3 | $655K | Sell |
285,064
-6,386
| -2% | -$14.7K | 0.73% | 44 |
|
|
2022
Q2 | $901K | Buy |
291,450
+11,600
| +4% | +$35.9K | 0.93% | 39 |
|
|
2022
Q1 | $1.02M | Sell |
279,850
-250
| -0.1% | -$908 | 0.83% | 45 |
|
|
2021
Q4 | $1.09M | Buy |
280,100
+124,800
| +80% | +$484K | 0.73% | 50 |
|
|
2021
Q3 | $980K | Sell |
155,300
-10,100
| -6% | -$63.7K | 0.61% | 48 |
|
|
2021
Q2 | $1.32M | Buy |
165,400
+25,500
| +18% | +$204K | 0.75% | 43 |
|
|
2021
Q1 | $1.53M | Buy |
139,900
+89,900
| +180% | +$980K | 0.88% | 40 |
|
|
2020
Q4 | $225K | Buy |
+50,000
| New | +$225K | 0.15% | 85 |
|